Guardant Health Form 144: 9,840 Common Shares

Guardant Health reported a Form 144 notice relating to the proposed sale of Common stock.

Rhea-AI Filing Summary

Guardant Health reported a Form 144 notice relating to the proposed sale of Common stock. The filing lists 9,840 Common shares with a filing date of 04/16/2026 via Charles Schwab. The excerpt also notes a restricted stock lapse on 02/15/2026 and a reported sale of 348 shares by Musa Tariq on 03/18/2026.

Insights

Securities Compliance Analyst

Form 144 lists a proposed sale of Common shares and recent insider activity.

The filing shows a proposed disposition of 9,840 Common shares filed on 04/16/2026 through Charles Schwab, and records a restricted stock lapse dated 02/15/2026. It also records a prior sale of 348 shares by Musa Tariq on 03/18/2026.

These entries are routine reporting of planned or recent transactions; cash‑flow treatment and pricing details are not included in the provided excerpt. Subsequent SEC disclosures or broker confirmations would show execution details if the sale occurs.

Key Figures

Proposed sale listed: 9,840 shares Recent insider sale: 348 shares Restricted stock lapse date: 02/15/2026

3 metrics

Proposed sale listed 9,840 shares listed with Charles Schwab, filing date 04/16/2026

Recent insider sale 348 shares sale by Musa Tariq on 03/18/2026

Restricted stock lapse date 02/15/2026 Restricted Stock Lapse referenced for Guardant Health

Key Terms

Form 144, Restricted Stock Lapse, Equity Compensation

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Lapse financial

"Common | 02/15/2026 | Restricted Stock Lapse"

Equity Compensation financial

"02/15/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's (GH) Form 144 disclose?

The Form 144 discloses a proposed sale of 9,840 Common shares filed on 04/16/2026. It also notes a restricted stock lapse on 02/15/2026 and a reported insider sale of 348 shares on 03/18/2026.

Who is listed as having sold shares recently for GH in this excerpt?

The excerpt lists Musa Tariq as having sold 348 shares on 03/18/2026. The filing shows this past three‑month sale separate from the Form 144 proposed sale.

Does the Form 144 show where the shares will be sold for GH?

The filing lists Charles Schwab & Co., Inc. as the broker/dealer for the proposed sale dated 04/16/2026. The excerpt does not include execution price or specific sale method details.

What is a 'restricted stock lapse' noted in the GH excerpt?

A restricted stock lapse dated 02/15/2026 indicates restricted shares became transferable on that date, commonly allowing subsequent sale or transfer under securities law and reporting requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Tariq Musa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	9840.00	131170441	04/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			116	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	03/18/2026	348	30655.00

144: Remarks and Signature

Remarks
Date of Notice	04/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Musa Tariq
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)